Investors

Copyright West LLC. Minimum 15 minutes delayed.

SEC Filings

Filing date Description Form Filing Group Issuer View

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

Filing by person(s) reporting owned shares of common stock in a public company >5%

SC 13D
3,4,5
Immunovaccine Inc. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Immunovaccine Inc. View HTML

EFFECT

EFFECT
Other
Immunovaccine Inc. View HTML

Amendment to a previously filed F-10

F-10/A
Other
Immunovaccine Inc. View HTML

Securities offered to employees pursuant to employee benefit plans

S-8
Registration Statements
Immunovaccine Inc. View HTML